
Pet Farm
Animal pharmaceutical distribution and manufacturing company.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
investor | €0.0 Valuation: €0.0 | round | |
* | KRW6.5b | Series B | |
Total Funding | 000k |
Related Content
Pet Farm, founded in December 2019 by CEO Yoon Sung-han, operates as a key player in South Korea's burgeoning pet-related economy. Yoon Sung-han, along with his son Yoon Su-ho, identified a market inefficiency where pet medications were predominantly sold at high prices through veterinary clinics, while pharmacies remained an underutilized channel. Leveraging his diverse background—which includes experience as a researcher, web programmer, and finance director—Yoon Sung-han launched the company to make animal pharmaceuticals more accessible and affordable.
The company's core business is a B2B e-commerce platform launched in May 2020, which supplies animal medicine, health supplements, and other pet products to a network of registered pharmacies. This model addresses the regulatory landscape in South Korea, where online sales of animal medicine to consumers are prohibited, by empowering physical pharmacies to become convenient access points for pet owners. Pet Farm supports its pharmacy partners by assisting with the process of registering as an animal pharmacy, managing inventory, handling returns, and providing ongoing support through regional managers. Revenue is generated from the sale and distribution of these products to its network, which has grown to approximately 6,000 member pharmacies by early 2025.
In addition to its B2B operations, Pet Farm has developed a B2C mobile application for pet owners. This app features a map to locate nearby partner pharmacies, provides information on over 300 veterinary drugs, and includes functionalities like medication reminders and diagnosis management through at-home urine test kits available at their pharmacies. The company has also established exclusive supply agreements with pharmaceutical companies such as Kwangdong Pharmaceutical and Kyongbo Pharmaceutical. A significant milestone was achieved in February 2025 when Pet Farm obtained a license to manufacture its own veterinary medicines, signaling its intent to nationalize production in a market dominated by multinational corporations and to launch its own branded products.
Keywords: animal pharmacy platform, veterinary medicine distribution, pet healthcare, B2B pet supplies, pet pharmaceuticals, animal drug e-commerce, pet owner app, animal health supplements, veterinary drug manufacturing, South Korea pet market, pet medication management, pharmacy network, animal medicine supply chain, pet care technology, Yoon Sung-han, veterinary product distribution, pet wellness